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Abstract. Nerve growth factor (NGF) and brain-
derived neuI'Otrophic faetar (BDNF) are molecules 
which regulate the development and maintenance of 
specific functions in different populations of peripheral 
and central neurons, amangst them sensory neurons of 
neural erest and placode origin. Under physiologica1 
conditions NGF is synthesized by peripheral target tis-
sues, whereas BDNF synthesis is rughest in the CNS. 
This situation changes dramatically after lesion of 
peripheraJ nerves. As previously shown, there is a 
marked rapid increase in NGF mRNA in the nonneu-
ronal cells of the damaged nerve. The prolonged ele-
vation of NGF mRNA levels is related to the immi-
gration of activated macrophages, interleukin-l being 
the most essential mediator of this effect. 
Here we show that transsection of the rat sciatic 
nerve also leads to a very marked increase in BDNF 
mRNA, the final levels being even ten times higher 
BRAIN-deriVed neucotrophic mctor (BDNF)i and nerve growth mctor (NGF) belong to a still growing fam-jly of neurotrophic molecules collectively called neu-
rotrophins (6, 60). These proteins shO\ll a similar basic struc-
ture reflected by conserved domains arranged around the six 
cysteine residues which seem to be of great importance in 
detennining the three-dimensional structure of these mole-
cules, aprerequisite for their biological activity. However, 
BDNF and NGF also show distinctly different variable da-
mains which detennine the different spectra oftheir neuronal 
specificity. 80th BDNF and NGF support neural crest-
derived sensory neurons in the periphery (placode-derived 
sensory neurons are supported only by BDNF and neurotro-
phin-3 {NT-3D (27, 28, 37). The etfe.cts of different neurotro-
phins on DRG neurons are additive in vitra (BDNF and 
NGF, see reference 37; BDNF and NT·3, see reference 28), 
suggesting that the various sub-popu1atioos of neurons are 
I . Abb1'l!Yi6lions used in thU paper. BDNF, brain-derivcd ncurotrophic &c-
tOT; DRG, dorsal root laqlion; FK, fOrskolin; IL-l. inlerleu.lrin-l; NGF, 
nerve growIh faclor: NT-3. neurotrophin·3. 
than those of NGF mRNA. However, the time-course 
and spatial pattern of BDNF mRNA expression are 
distincdy different. There is a continuous slow in-
crease of BDNF mRNA starting after day 3 post-Iesion 
and reaching maximal levels 3-4 wk later. These dis-
tinct differences suggest different mechanisms of regu-
lation of NGF and BDNF syothesis in non-neuronal 
cells of the nerve. This was substantiated by the dem-
onstration of differential regulation of these mRNAs in 
organ culture of rat sciatic nerve and Schwann cell 
culture. Furthennore, using bioassays and specific anti-
bocHes we showed that cultured Schwann cells are a 
rieh source of BDNF- and ciHary neurotrophie faetor 
(CNTF)-like neurotrophic activity in addition to NGF. 
Antisera raised against a BDNF-peptide demonstrated 
BDNF-immunoreactivity in pure cultured Schwann 
cells, but not in fibroblasts derived from sciatic nerve. 
supponed by different members of the NGF gene family in 
a panly overlapping manner. Under physiological as weU as 
cu1ture conditions NGF is produced in target tissues of mi~ 
peripheral nerves, such as skin and ins (4, 7,13,14,20,21, 
54,55), whereas BDNF expression has not been detected in 
the periphery, with the exceptions oflung, heart, and skeletal 
muscle (26, 33, 40) where the ceUular site of synthesis re-
mains to be estabüshed. However, in the central nervous sys-
tem (eNS) expression of BDNF mRNA is more extensive 
including the spinal cord (26, 40. 68). Therefore, it seems 
reasonable to assume that DRG sensory neurons obulin 
BDNF via their central processes. BDNF mRNA has re-
cently also been detected in DRG neurons (15, 16). It re· 
mains unclear whether conditions exist where these neurons 
are supplied with BDNF in an autocrine or paracrine 
manner. 
NGF is not expressed to a significant cxtent in oon-
neuronal cells of adult peripheral nerves (22). However, this 
situation changes dramatica1ly after nerve lesion. A rapid, 
transient. and massive increase in NGF mRNA occurs in the 
nerve region immediately proximal to the lesion and a1l 
along the distal nerve segment. This rapid increase is fol-
lewed by a second increase in NGF mRNA which lasts sev-
eral weeks. The second long-Iasting increase is mostly due 
to IL-l released by macrophages invading the lesioned nerve. 
Tbis ean be deduced from the observation that the second in-
crease of NGF mRNA in vivo coincides with the invasion of 
macrophages at the lesion site (23). An initial rapid increase 
without the subsequent second phase is observed in nerve or-
gan culture. However, the second increase of NGF rnRNA 
observed in vivo can be mimicked by the addition of acti-
vated macrophages or even recombinant IL-l to organ cul-
tures (23, 36), and can be blocked by IL-l antibociies (36) . 
The role played by macrophage-secreted IL-l is further sup-
poned. by the recent observation that the mouse strain Ola 
(wh ich is defective in macrophage invasion into lesioned 
nerves) only shows the rapid immediate increase and a much 
smaller secondary increase in NGF mRNA (9). This smaller 
increase is paralleled by the lewer increase in IL-IP' mRNA 
corresponding to the highly reduced invasion of macro-
phages (24). We have new analyzed the expression of BO NF 
mRNA, BONF-like activity and the localization of BDNF-
like inununoreactivity in the transsected peripheral rat nerve 
and in isolated Schwann cells and fibroblasts ofthe rat sciatic 
nerve. As previously shown for NGF. BDNF mRNA in-
creases to high levels after lesion. Hewever, the time-course 
ofme elevation ofBDNF mRNA levels is distinctJy different 
from that of NGF mRNA. In contrast to NGF mRNA, the 
increase in BDNF mRNA distal to the transsection site is 
monophasic and takes place at a much slower rate, reaching 
maximal levels at approximately four weeks posttranssec-
tion . The maximal BONF mRNA levels are about 10 times 
higher than those of NGF mRNA. These observations 
demonstate that different regulatory mechanisms control the 
levels cf BDNF and NGF mRNA in the lesioned nerve in 
vive. Specifically, IL-l does not alter BDNF mRNA levels 
in explant cultures of sciatic nerve. Moreover, in vitro syn-
thesis of BONF is restricted to Schwann cells and the levels 
of BONF and NGF mRNA in these cells are differentially 
regulated. 
Tbe massive increase in BDNF mRNA in sciatic nerve and 
in isolated Schwann cells is of panicular interest in view of 
previous observations that peripheral nerve grafts and 
Schwann cells proved to be conducive for the regeneration 
of central neurons, in particular retina! ganglion cells (31, 
39,59,64) and dopaminergic striatal neurons (li, 12, 17, 30, 
62) which are supponed by BDNF, but not by NGF. 
Matl!rials and Methods 
Materials 
FoBkolin a(J.lcet<»;y-8,13-epoxy-Lafltj,9a-trihydroxyllbd-1 4-ene-ll-one); 
ionomycin; phorbol 12-myristlte 13-acetlte (TPA); 8-broIl'llK:AMP; Ind 
N'I-bc:nzoy1-cAMP were purcilas«l (rom Sigma Chemical Co. (Deisen-
hofen, Gennany). Purified porcine mF.BI WlS obtained from British Bio-
Tcchnology (Oxfonl, England). Human recolllbinant lL-l~ was I genemus 
gift oe Drs. A. Gronenborn (Max-Planck-Institute for Biochemistry, Mar-
linsried , Gennany) and P. Wmglield (BiogeniGlaxo, Genevl, Swiu.erllnd). 
Recombinant Proteins and Antibodies 
Recombilllnt ntOlliC NT-3 was produced and purified as dcscribcd by Göu 
CI 111. (1992) . Rccombilllllt mouse BDNF ."".s produced by the same 
method. TIIcy were generou:!ly provided by Y.-A. Barde and R. Kolbcck 
(Mu-Planck-Institute for PS)"Chiltry, Depanmenl ofNeurochemistry, Mar-
linsried, Germany). The biological Ictivity of rewmbinant BONF was 
identicil 10 that of BDNF purified from pig bl'llin (27). BDNF-peptide 
specific IlI\tisera were produced and. dwacteriz.ed as prcvious1y dc:scribcd 
by Wetmore et al. (1991). Bridly, pol)'donal llI\Iisera l\llye been raised 
against a synthetic peptide deriYed from BDNFm.!fl. RecQmbinant rat 
CNTF was a kind gift ofM. Sendtner (Max-Planck-Institute for Psychialry, 
Departmcnt of Neurochemistry, MBrtinsried. Germany) and was produced 
as describcd by Masi.aka.>n;lci eil!. (1991). The CNTF antiserum was kindly 
provided by M. Sendtner. Tt was raised by immunizalion of rabbil5 with 
=mbinant rat CNTE An IgG fraction was purified on a protein G column 
(Pharmacia Fine Cilemicals, Freiburg, Germany) IlCCQnlinglo tne manufac-
turer's instructions, dial)'ud eJltensivety. lyophilizcd, and used at the indio 
cated concenlrations. 
Surgical Procedures 
Wistar ral5 (180-250 g) were ether anaesthetized an(! a 7-1Q-nun piece of 
the right sciatic nerve was resected with minimal damage of surroonding 
tissues. No funher attempts were nade, such as ligation or deflcclion ofille 
proximal stump, to prevenl rcinnervation of the distal slUmp. Clips were 
use([ 10 close the wound. After indicated limes ral5 were kille(! by cervical 
dislocation alld the nerves dissected acconling 10 the scheme prcsenled in 
Fig. I 8 and rapidly frozen in liquid nitrogen. 
Cell Culture 
Pieces of adult and newbom rat SCiBlic nerve (six pieces of 5·nun length) 
were kept in culture (10% FCS, OME) ror 3 d with daily changes of media 
as previously describcd (23, 44). Tbc indicated treatments were staned the 
thini day. 
Schwann cell cultures were performed as previously describcd in dctail 
by Mal5uou et a1. (199lb). Ouring selection and eJlpansion of cullUres 
cytosine-arabinoside and f()l"5kolin (FK) werc used . flora discussion ofpos-
sible inftuences ofthese drugs of Schwarm etll phenotypc l nd NGF mRNA 
eJL: pression see Mal500ka el al . (199lb) . 
The dissociation and tiuue digestion methods used rar Schwann cdl cul-
IUres have also been used fur fibroblast cultures derived from nerves of 1-3-
d-old TalS. Cytosine·arabinoside selection was Ilowever omined. Such cul-
lures normall)' develop intocullures lleavily contantinated by SclIwann cells 
situated abeYe a fibl'Qblast monolayer. Schwarm cells were eliminated from 
thC$Ci cullures by treatment with 10 ~M FK stllrting the second day in Yitm. 
Consistent with previous observalions ScIlWll/ln cells need, in additioo 10 
FK an(! growth factOr5 comaincd in FCS, 11 specitic substrale, in this case 
poly-lysine, to proliferate (47, 6.5). However, Ilbroblasts from the same 
nerves g!'(/W in FK-conlailling media on plain tissue culrure plastic. Seven 
to nine days after initiation of the FK treatmenl conftuenl monolayers of 
fibroblasts (charllClerized by indim:1 immunoftuorescence as dcscribed. by 
Matsuoka el a1 .• 1991b) (:>90% Thy 1.\ positive [OX7 monoclonal], <10% 
SIOO positive) were oblained. These were passaged once withoul FK. 
g!'(/Wn to conftuency and used fuT eJlperimenlS after at leasl one additional 
medium change. Thus. ther wert kept withoul FK for 111 leasl 8 d. 
Northem Blot 
Northem blat analysis of mRNA \WS perfonned as previousl)' described in 
deta.il (20, 44). Briefty, total RNA Wls isolated from cultured cell, and 
Ilomogenized tissue by the ACid phenol method (10), dcnaturcd. and sepa-
raled on agarose gels, vacuum-btotted to nylon and probed with a NGF 
cRNA probe (44) , a BDNF cRNA probe (26) or a Po cONA probe (34) . 
10 allow foT correction oe different eJL:traction efficiencies a D.5-kb synlhetic 
NGF-RNA or BDNF-RNA were included during eJltraction. AUloradio-
grams were scanned by laser densitometry. AbsolllU: arnounlS or specific 
mRNA were calculated from standards llI\alyzed simullaneousl)' on each 
ge!. VBlues were corrected for differences in eJltraction efficiencies and 
length of transcriptS. Tbc absolute amounts of BDNF mRNA are given for 
the sma11er of Ihe ~ transcripts. 
Bioassays 
The bioassay on dissociatcd ES chick ciliary neurons has beeil described. 
previously (29). Initially plated neurons and neurons surviYing in tbe pres-
ence of samples after 24 h were counted. Resull5 were calculated as giyen 
in the labte legend. Samplcs tested in Ibis bioassay were celJ culture media 
conditioned for 3 d on a conftuenllayer of Schwann cells CU!llIred as dc· 
scribed abeYe. AI the time of conditioning these etUS hall received at leut 
thrce medium cltanges 10 FK-frce medium. Thus, they bad been kepl foT 
al leut 10 d without FK. Cooditioned media were ctntrifuged (400 g) 10 
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Figu~ J. (A) BDNF mRNA in different segments ofthe transsected 
sciatic nerve 17 d after lesion. p, proximal segments; D, distal seg-
ments. Labeling of segments is indicated in B. (8) Dissection 
scheme. 
rernove cellular debris and frozen until use. Final dilutions of conditiQned 
media in the bioassay are irtdicatod in tbe lable legend!;. Wells usa! to usay 
reoombinaru pmteil15 and contmls reccived an cqual amount offresb DME, 
10% FCS which was also used for Schwann oell cultures. 
The bioassay on dissociated chick E8 nodose ganglion neurons _s per-
formed as previously dcscribed (37). Resultos wcre obtaincd after 72 h of 
cultllre as describcd in tIIe table legend. Conditioned media wcre prepared 
as detaiJed for the eiliary neuron bioassay but wilhout dilution. 
A B 
lmmunojluorescence ofCultured Cel/s 
Cultures used foT slaining _re either ex.pandod cultures as describod above, 
mixed cultures obtained after culturing for 2 d without cytosine-arabinoside 
sclection or mied cultures obIaincd by co-culture of purified expanded 
populations ofSchlWnn cells and sciatic fibrobla5Ui (see above). Cells were 
passagod 10 poly-lysine-coated glass covers/ips and cultured for 1-3 d be-
fore fixatiQn (15 min) at room ternperature in 4% PFA, 0.1% picoc acid. 
Incubatiol'lS wilh antisera serving IIS lirst antibod.ies were performed (IIIer-
night at Ihe indicated dilutions IIS described (67). Tb llIduce ul15pecilic stain-
iog j % normal horse serum was added 10 Ihe prirnary antiserum incuba-
tions. Primary antibodies wcre detected using a biotinylaled anti-rabbi! 
antibody (1:100) (Amersh.am Corp., Arlington Heighls, lL) and a strep-
tavidin-FITC or streptavHlin-Texas Red conjugate (1:200) (Amersham 
Corp.). EpiHoo~ microscopy \WS perforrned on a Zeiss lI.liopllQ( mi-
croscope (Carl Zeiss, Oberkochen, Germany). Antisera from different rab-
bits lind a protein-A-purified IgG fTaction of one of lbem have been used 
foT Ihc staining uperimcnts. 
Results 
Effect 0/ Sciatic Ne1'Ye Transseetion on BDNF mRNA 
Lew!ls in the Nene Sheath 
In a first series of experiments we analyzed the expression 
of BDNF mRNA in inlact and transsected sciatic nerves of 
adult rats. A 7-10-mm piece of nerve was resected unilater-
ally and two segments of 5-mm length proximaJ and distal 
10 the lesion were used for the quantification of BDNF 
mRNA levels at the indicated limes after transsection (Fig. 
1 B). Comparisons were made on a wet weight basis. Basal 
levels are below the detection limit (16 fglmg wel weight). 
Clearly elevated levels of21O fglmg wet weighl were first 
detected 7 d post-lesion dislal 10 the transsection site (Fig. 
2). This increase in BDNF mRNA level continued until620 
fg/mg was detected 21 d post-Iesion. A much smaller in-
crease was observed between day 21-28. In no case were 
fiber strands bridging the gap between the distal and prox-
imal sturnps observed during dissection. As a control for 
possible regeneration, blots were reprobed with a rat Po 
cDNA probe. It is weil established that Po mRNA is down~ 
regulated in distal parts of transsecled peripheraJ nerves and 
slays at a low level as lang as regenerating fibers do not reach 
the distal Schwann cell bands (61). All nerves analyzed more 
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Figure 2. (A) For oomparison, the time course 
of NGF mRNA changes in the first distal seg-
ment of the uans~ rat sciatic nerve is 
shown (taken from reference 17). (B) Tune 
course of BDNP mRNA changes in the first 
distal segment D1 after resectioD as described 
in Materials and Methods. Levels er BDNP 
mRNA at day I through day 3 after lesion 
were below the detection limit (16 fglmg wel 
weight). Average and SO of three independenl 
ellpenmenl5 are shown. 
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fi8ure 3. Comparison of BDNF mRNA and NGF mRNA in new-
bom nerve organ cultures. (Top) BDNF mRNA; (botrom) NGF 
mRNA. (Standard) NGF recovery standard. (lL-lB) SO Ulml , 3 h; 
(10" ) ionoIll)'Cin, 1 .uglml, 3 h. For each treatment duplicate sam-
pIes are shcrwn. 
than 14 d after Jesion did not contain detectable Po mRNA 
in distal segments (data not shOlNn) . 
Interestingly, the elevation of BDNF mRNA levels was 
restricted to distal segments and was most pronounced in 
the segment inunediately distal to the transsection site (Fig. 
I A). 
As described for other tissues, BDNF mRNA was detected 
as two bands of 1.5 to 1.7 kb and "'4.6 kb. No additional 
bands were seen. The molar ratio of the small to long tran-
script was "'3 at alJ tirnes after lesion (Fig. 1 A) . This ratio 
is similar to the one described for other tissues (26, 40) . 
Regulation 01 BDNF mRNA Levels in Nerve 
Organ Culture 
Since the maximal increase in BDNF mRNA in vivo was not 
reached before 2 wk post-lesion a regulatory role fot 
secteted macrophage products is unlikely. As described eat-
lier, administration of lL-Iß (which is a major product 
release<! by activated macrophages) to nerve organ cultures 
derived from newbom or adult animals resulted in a marked 
increase in NGF mRNA (36, 44). However, this was not ac-
companied by any change in BDNF mRNA levels (Fig. 3). 
Similar results were obtained in adult nerve organ cultures 
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Fi8ure 5. Tune eourse ofthe effect ofionomycin on BDNF mRNA 
levels in cultured Schwann cells. IOßOOlycin was given at I .uglml 
for the indicated times. Duplieate sampies are shawn. 
(data not shown) . Basal levels ofBDNF mRNA in these cul-
ture systems were c1early detectable and higber than levels 
in intact nerve in vivo. This effect of culturing has also been 
previously observed for NGF mRNA levels. However, 
BDNF mRNA levels in organ culture were not maximal as 
they could be further increased by ionomycin treatment (Fig. 
3). This is in agreement with the data obtained in Schwann 
cell cultures (see below) . 
Regulation 0/ BDNF mRNA in Cultured Schwann 
Cells by Polypeptides and Second Messenger Rlthways 
The analysis was extended to Schwann ceUs as the most 
abundant non-neuronal ceU type cf the sciatic nerve. As 
reported previously, cultured Schwann ceUs prepared from 
newborn sciatic nerve constilUtively express BDNF mRNA 
(1, 43) (Fig. 4 , lanes 1 and 2, control). This basal expression 
amounted to "'18 pgfl(}l ceUs. Thus cultured Schwann cells 
contain clearly elevated amounts of this mRNA compared 10 
BDNF mRNA levels in intact nerve. Administration of 
ionomycin resulted in a rapid increase of BDNF mRNA lev-
els (two- to threefold) similar to that found in organ cultures 
(Fig. 5 and Thble I). The effect of ionomycin could be further 
potentiated by co-administration of TPA ("'IO-fold) (lllble 
1) . TPA alone had a small suppressive effect on BDNF 
mRNA levels (Thble n. 
Besides the two mRNA transcripts referred to above no ad-
ditional band was seen . The ratio of small to long mRNA 
was, again , "'3. 
In agreement with the results reported for nerve organ cul-
ture no effect of IL-l was observed (lllble 1). 
contr o l FK DFK 8-Br 6-Ben 8-Br 
6-Ben 
Figure 4. Regulation of BDNF mRNA in 
cultured Schwann cells by cAMP. (FK) for-
skolin, IO.uM ; (DFK)dideoxyfonkolin , 10 
pM; (8-Br) 8-bromo cAMP, o.S mM ; 
(6-&") N6-benzoyl-cAMP, 05 mM; (8-8r) 
6-Ben: combination ofboth, each 05 mM. 
All treatments were done fot 3 h . Duplicate 
sampies are shawn. 
Tab/~ J. R~gulation o/Schwann C~II BDNF mRNA LeW!/s 
by Growth Factors and Signal Transduction Pathways 
Conlrol 
FK 
TPA 
IONQ 
IONO + FK 
IONO + TPA 
IL-I,6 
TGF-,61 
BDNF rnRNA relative 10 oomrol 
1 
0.33 ± 0.06 
0.7 ± 0.17 
2.7 ± 0.36 
0.7S ± 0.21 
9.7 ± 1.9 
0.9 ± 0.21 
O. I8 ± 0.02 
BDNF rnRNA levell or CU1Nrcd Schwann ulll were ana1yzed by quantitative 
Nonhem bloaina aIId values (avetll,e ± so of three independen! dt;tennina· 
!iom) are Jiven rel.!ive to controllevels whieb were Se! I . Facwrs used: (FK) 
10,.M, 3 h; (TPA) 100 nelml. 3 11 ; (IONfJ) ionomycin, 1 ... glmI, 3 11: (or 00In-
binations tbe 5aITIe C()II(:entrations wen applied for 3 h: (TGF-bl) I nglml. 
24 h; (/&/fj) recombinant lIuman IL-l ,B, .so UlmI, 3 h. 
Interestingly, FK which is a direct activator of adenylate 
cyclase and induces NGF mRNA in Schwann ceUs, reduced 
BONF mRNA levels reptoducibly to 33% of basal levels 
(Fig. 4) . Dideoxyforskolin, an analogue of FK which does 
not activate adenylate cyclase, failed to reduce BDNF 
mRNA. Furthennore, membrane-permeable derivatives of 
cAMP also elicited a reduction ofBDNF mRNA levels corn-
parable to that seen with FK (Fig. 4) . The effect of cAMP 
elevation by FK could not be suppressed by an inhibitor of 
protein kinase C (H7, 50 pM) nor, remarkably, by an inhibi-
tor ofprotein kinase A (H8, 50 pM) (data not shawn) (25). 
Forskolin treatmeDl also suppressed the increase of BDNF 
mRNA levels induced by ionomycin (Thble 1). Treatment 
of Schwann cells with TGF-ß I which has previously been 
shown 10 reduce basal NGF mRNA expression (44) also re-
sulted in a dear reduction ofBDNF mRNA levels (Thble 1) . 
Fibroblast cultures purified and expanded as described in 
Materials and Methods contained "'10% of the BDNF 
mRNA levels detennined for Schwann cell cultures when 
equal amounts oftotal RNA were analyzed (datanot shown) . 
Neurotrophic Activity in Schwann 
Cell-conditioned Media 
This series of experiments was perfonned with the goalto 
establish whether the BDNF mRNA levels in Schwann ceUs 
are reflected by a corresponding ptoduction of BDNF-Iike 
activity. Since neither a specific imrnunoassay nor blocking 
antibOOies for BDNF are available, the determination of 
BDNF-Iike activity depended on an appropriate bioassay. 
To eva1uate the presence of cross-reacting neurotrophic ac-
tivity we initially tested Schwann cell conditioned media in 
an assay using ciliary ganglion neurons. These neurons da 
not respond 10 BDNF or to NGF (37; see reference 52 and 
data not shown). This assay was chosen to investigate the 
presence of CNTF, which has a potent neurotrophic activity 
on a large varie[)' of neurons (see reference 52) and thus 
might interfere with other bioassays. Schwann cell-con-
dilioned media contained enough CNTF-Iikt; activity to res-
cue "'50% ofthe plated neurons at a VlOdilution (Thble m. 
A polyclonal antiserum produced againsl recombinanl rat 
CNTF, which completely blocks the effect of 1 nglml of te-
combinant CNTF. reduced the survival activity of Schwann 
cell-conditioned media to 15% . 
Dissociated nodose ganglion neurons of E8 chick were 
Tabl~ 11. N~urotrophic Activity 0/ Schwann 
C~Il-condition~d Media: Bioassayon E8 Chiclc 
Ciliary Ganglion N~urons 
'''''''' "'" 
SC-CM 
SC-CM + anti-CNTF. S ~glmJ 
SC-CM + anti·CNTF. 10 pglml 
SC-CM + anti-CNTF. 20 PI/mI 
SC-CM + anli-CNTF. 40 pglm.! 
CNTF 
SC-CM + CNTF 
54 ± 12.9 
19' 
13' 
IS ± 2.S 
11' 
93 ± 12.7 
.,. 
The uuy 10'11 performed on dillOCiated E8 clticlr. ciliary lanalion IICVrotll . 
Sl.irviYin, ceU, were oounted Ittet 45 h and perccntap wert: cak:ulltod as fot 
ralllt: IU. Bacqround lurvival was O~ in aU experimenlS. If IlOl indica&ed 
otherwise Iverage ± SO were ealculltod from three indq:Jerwknt experiments 
ISSlyin, three differen! Schwann cell-wnditionc:d media. 
(SC·CM) ObWned as livtn in Material , and Methods. uKd at a final dillition 
of 1/10; (CfflF) recombinant rat CNTF, 1 ng/mI; (anti·CNTf) neutra/iunl 
CNTF antiserum u deseribed . 
• SinaJe vailie. 
~ Average of!Wo independent experiments using two different SC.cM. 
used as a BONF·sensitive bioassay. In confinnation of previ-
ous results (52), recombinant CNTF has a substantiaI sur-
vival etrect in this assay which can however be blocked by 
CNTF-antiserum (data not shown). Thus anti-CNTF antise-
rum was added to all sampies. Native undiluted conditioned 
media showed high survival activity in Ibis assay, rescuing 
86% of all plated neurons (Thble llI). Inclusion of anti-
CNTF resulted in a reduction to 53 % surviving neurons. 
Oue to the unavailability of neutralizing antisera against 
BDNF it was necessary 10 use an indirect way to demonsttate 
!hat the remaining activity, at least in part, represented 
BDNF-likt; activity. If Schwann cell-conditioned media 
were to contain saturating concentrations of BDNF, one 
would predict no increase in survival activity by addition of 
recombinant BDNF. Addition of a saturating dose of BONF 
to anti·CNTF treatcd sampies resulted in only a small in-
crease of neuronal survival (Thble Ill). The same concentra-
tion of exogenous BDNF alone in the presence of anti-CNTF 
rescued 37% ofthe plated neurons. Thus the lack of a distinct 
additional effecl of exogenous BDNF suggests that Schwann 
Tabl~ 111. Nturorrophic Activity 0/ Schwann 
C~/l-conditi01led Media: Bioassayon E8 Nodost Ntu.rons 
SC-CM 
SC-CM + anti-CNTF 
SC-CM + anti-CNTF + BDNF 
anri-CNTF + BDNF 
SC-CM + anli-CNTF + NT-3 
anti-CNTF + NT-3 
anti-CNTF + BDNF + NT-3 
Pt:~m specilk SIIrvivai 
86 ± S.7 
S3 ± 3.6 
60 ± S.7 
37 ± 9.S 
70 ± 3.2 
34 ± 6.4 
63 ± 4.9 
The aHly WIS ptrfonned on dilSOCiatc:d ES dUclr. DO(\ose pn,lion neurons. 
Survivina oelb .her 72 h in culNrt: were eakulatcd u a peroentqe of initiaJl)' 
plated ull •. Survival wi!boll! added ranon has Ileen wbtraeted (baeqroulld 
valllQ for!he tbree experimeDu clone wen: I, 10. 2~). Average. ± SO of 
three independent experimen!1 ~yin, three düferent samples of SchwanD 
«11 oolll1itioncd medil an: &iven. FIeIOI'1I addcd: (SC.cM) Und.iluted Schwl.l!.l\ 
oell conditioned medillm. oonWning 10'1 FCS, oonditioned for 3 d: (aNl-
CNTF) 19O-fraction of a neutraJirina CNTF antiiervm I! 10 ... elm!; (BDNF) 
recombinant IllOIIIe BONF, I ngiml; (NT-l) recombilWlt mou.se NT-3, 
I ng/ml. FleIOrs were added 0IlCe and were prt:sent througbout!he wbole cul· 
Nre period. 
cell-conditioned media contained concentrations of BDNF-
like activity which were close to saturation. 
Addition of a saturating concentration of recombinant 
NT-3 to anti-CNTF treated conditioned medium sampies 
resulted in higher increases of survivaI activity (Thble m). 
This percentage is lower than the one achieved by addition 
of NT-3 alone. This and the faet that Schwann eell-<:on-
ditioned media in the presence of neutralizing CNTF anti-
bodies rescue 16% more neurons than BDNF alone suggests 
that these media contain a faetor aeting on NT-3 responsive 
neurons. The molecular identity ofthis neurotrophic aetivity 
has not been elucidated. lt eannot be excluded that it, at least 
partly, represents NT-3, although preliminary Northem blot-
ting experiments did not reveal the presence of NT-3 mRNA 
in cultured Sehwann eells (levels were lower than "'250 
fgllQ6 ceils) (data not shown). For comparison. Schwann 
cells eultured as described here contain rv5.6 pg of NGF 
mRNA/I06 eells (44) and "'18 pg of BDNF mRNAJ1()6 
cells (see above). 
Intracellular Localization 0/ BDNF-like 
Immunoreactivity 
In an attempt to provide more direct evidenee for the pres-
ence of BDNF protein in Schwann ceUs we used antisera 
raised against a peptide sequenee contained in BDNF for im-
munostaining studies of eultured Schwann ceUs. These an-
tisera have previously been extensively charaeterized by 
Wetmore et al. (1991). As our Northem blot analysis of 
fibroblasts derived from newbom sciatic nerves showed. on1y 
very linIe specific BDNF mRNA. we used mixed cultures 
of Schwann ceUs and fibroblasts to provide an internal con-
tral of staining specifieity. 
These experiments reveaJed clear and even1y distributed 
staining of Schwann ceUs (Fig. 6 A). Most of the ftat large 
ceUs present in the eultures were identified as Thyl positive 
and SI00 negative in separate immunostainings and thus 
probably represented fibroblasts. In most ("'90%) of these 
cells no staining could be detected. However, "'10% of the 
ftat cells showed a staining comparable in intensity to the 
staining of Schwann eeIls (Fig. 7 A). Closer examination of 
the staining revea1ed an exclusively extranuclear signal in 
both positive cell types (Figs. 6 A. and 7 A). In many cells 
the most intensive staining was restricted to the perinuclear 
area (Fig. 6 A.). However. a faint but clear signal was also 
detected in Schwann eell processes. At bigher magnification 
the staining in Schwano cells appeared granular (Fig. 6 Cl. 
Antisera obtained from two different rabbits, and an IgG 
fraction purified from one of them. gave similar results. 
Discussion 
Comparison 0/ the Expression Fonem 0/ BDNF 
mRNA and NGF mRNA after Nerve Lesion 
The data presented provide evidence that synthesis ofBDNF 
is upregulated after peripheral nerve lesion in non-neuronal 
ceUs of the nerve sheath. A similar augmentation of synthe-
sis has pm-iously been reJX>rted for NGF (22). However, 
there are striking differences between the two neurotrophins 
regarding the time course, the magnit1lde of the response and 
its localization. The biphasic increase in NGF mRNA is 
characterized by a first very rapid and transient increase 
peaking at "'6 h after lesion and a second prolonged one 
starting around 2 to 3 d after lesion (22). In contrast, there 
is no detectable increase in BDNF mRNA fot up to three 
days after lesion. Thereafter, amounts ofBDNF mRNA rose 
slowly and reached maximal levels after 2 wk after lesioo. 
There is good evidence thal macrophage-derived IL-l is 
responsible for the second phase of tbe NGF mRNA io-
crease. Since a maximum of macrophage invasion and acti-
vation at the lesion site occurs between day 2 and 6 after 
transsection (&, 46), prcxlucts of stlmulated macrophages are 
not likely to playa role in the delayed and prolonged increase 
of BDNF mRNA. This notion is supported by the lack of 
effect ofIL-l on BDNF mRNA levels in nerve organ cultures 
which are a reasonable model for IL-I- mediated NGF 
mRNA regulation (23). 
Interestingly. high levels of BDNF mRNA are found aJ-
most exclusively in distal nerve pieces. In oontrast, a 
significant increase in NGF mRNA has been detected in the 
nerve stump immediately proximal to the lesion site which 
is also invaded by macrophages. Therefore this difference in 
the localization oftropbic factor again might be explained by 
macrophage-independent BDNF induction. 
Additionally, a biphasic production of neurotropbic activ-
ity has been previously described for rat DRG neurons by 
Windebank and Poduslo (1986). Distal nerve pieces dis-
sected 3 to 7 d after transsection produce an activity which 
can be partly blocked by antisera to NGF. A second phase 
of produetion of neurotropbic activity which could not be 
blocked by these antisera was observed in pieces undergomg 
degeneration for 2 to 4 wk. This observation might be ex-
plained by the initial rapid release and produetion of NGF 
(22) and CNTF (41, 53, 69) and the delayed production of 
BDNF described here. lt is unlikely that CNTF is responsi-
ble for the second phase since nerve lesion leads to a rapid 
decrease in CNTF mRNA and. with some delay. CNTF pro-
tein (53). Nerve pieces distal to a crush lesion or transsec-
tion have also been shown to produce survival activity for 
retinal ganglion ceUs (59). Retina.l ganglion cells of adult rats 
after optie nerve lesion (59) and of embryonic rats (31) in 
eulture can be kept alive by BDNF. The activity in sciatic ex-
udate was not additive to BDNF suggesting that it was identi-
cai to BDNF (59). CNTF does not affect the survival of cul-
tured embryonie retinal ganglion ceUs (31). 
Under normal conditions both NGF and BDNF mRNA 
are barely detectable in intact sciatic nerve. However, the 
levels of both mRNAs are up-regulatcd after nerve lesion. 
The maximal tenfold higher levels of BDNF mRNA as oom-
pared to NGF mRNA indieate that ceUs of the nerve sheath 
under the appropriate circumstances can be a very rieh 
source of BDNF. This is aJso interesting in view of the fact 
that BDNF has been regarded primarily as a centrally pro-
duced neurotropbio and that expression of BDNF mRNA 
outside the CNS has initially been detected in only two pe-
ripheral organs (lung and heart) (26, 33, 40) and later also 
in a subpopulation of DRG neurons (15, 16). BDNF mRNA 
has not been detected in adult mouse skin (40). Recently. 
however, coostitutive levels of BDNF mRNA have been de-
scribed in poly-A" RNA of newborn rat skin (1). The rea~ 
sons for this discrepaney are unclear. Species and age differ-
ences, as weil as the amount of RNA analyzed (rv eightfold 
more in the study by Acheson et al . , 1991), may be respon-
sible. 
Figure 6. lnununolocalization of BDNF in primary mixed cultures of Schwann ceils and fibmblll5ts after 2 d in viuo. (a, epifluorescencc) 
Schwann cells (smallarrows) show mainly perinuclear staining. Nuclei are spared. (b, phase contras!) One fibmblll5l (Long arrow) is nOI 
stained in a. (c, epifluoresceoce) At bigher magnification slaining ofSchwann cclls appears 115 diffuse granules extending ioto cell processes. 
Whole antiserum diluted 1:500 was used. Ban: (a and b) 50 .um; (e) 25 .um. 
Regulation 0/ BDNF mRNA and NGF mRNA 
in Cultured Schwann Cells 
Our dala clearly demonstrate a differential regulalion of the 
levels of BDNF mRNA and NGF mRNA in cultured 
Schwann cells and nerve organ cultures. In contrast to the 
six- to ten-fold increase in NGF mRNA levels induced by 
elevation of intracellular cAMP (44), a signHicant reduction 
of basal as weil as ionomycin induced levels of BDNF 
mRNA is observed in cultured Schwann cells. This finding, 
together with the differential regulation observed in organ 
culture and the differences in the time course and localization 
of expression after lesion, suggests that fundamentally 
different mechanisms regulate the expression of these SlrUC-
turally related proteins. It is, bowever, not clear whether a 
situation anaJogous to cAMP elevation in culture occurs in 
vive during degeneration/regeneration or development and 
what the extraceUular signals mediating such changes might 
be. Stimulation of another set ofkinases (particularly protein 
kinase c) by TPA had a weak suppressive effect on BDNF 
mRNA levels. A strenger suppressive effect has previously 
been observed on NGF mRNA levels (44). IDF-ßl exerts 
a strong suppressive effect on basal as well as stimulated 
NGF mRNA levels (44) and a similar elfect On BDNF 
mRNA expression . Whether kinases activated by phorbol 
esters or signal transduction pathways activated by TGF-ß 1 
might playa role in down-regulation of neurotrophin expres-
sion after regeneration, or in the maintenance of low neu-
rotrophin levels in intact nerves deserves further investi-
gation. 
Ri!Ü!QSe 0/ Neurotrophic Activities by Cultured 
Schwann Cells 
An important question is whether Schwann cells produce 
and release active BDNF protein. The tools available to 
study this question are stilllimited. With the discovery of ad-
ditional neurotrophins acting on partly overlapping sets of 
target neurons, it is difficult to assure mOllOspecificity of any 
bioassay used. Furthennore, neutralizing antibodies against 
BDNF are not yet available. We chose to assay survival of 
ES chick nodose ganglion neurons since these neurons are 
responsive to BDNF, which may be released from Schwann 
cells after lesion, and are not responsive to NGF which is 
also present in Schwann celJ-conditioned media (3, 44, 49) . 
This bioassay does not distinguish between BDNF and NT-3, 
which support survival ofthese neurons in an additive wh-
ion. Additionally, ES chick nodose neurons also respond to 
CNTF (52) which is known to be expressed in sciatic nerve 
and in SchWanll cells in vivo as well as in vitro (35, 48, 53, 
56, 57) . Therefore we quantified CNTF-like bioactivity in 
Schwann cell-conditioned media. We were surprised to 
detect a relatively high rate of survival of ciliary ganglion 
neurons. indicating a strang CNTF-like activity. The cDNA-
derived amino acid sequence of CNTF does not provide evi-
dence for an aminotenninal signal sequence and CNTF is 
not released from transfected cells (35. 57). Thus CNTF is 
not thought to be secreted from cells. Furtbermore. cultured 
Schwann cells express relatively low levels of CNTF mRNA 
as compared to astrocytes (57) . These apparent discrepan-
eies can be reconciled by the fact that the CNfF protein is 
relatively stable (53) and that high amounts of CNTF-like 
neurotrophic activity have been detected in Iysates of cul-
tured Schwann cells. Leakage from a small nwnber of cells 
which are either damaged or are undergoing transient mem-
brane disturbances might be sufficient 10 explain the ob-
served survivaI activity. However, it cannot be excluded mat 
CNTF is released via an alternative mechanism. Schwann 
cell conditioned media appear 10 contain additional neuro-
Figure 7. Immunolocalization of BDNF in primary 
mixed cultures alter 2 d in vitro. (a , epiftuores-
cence) All Schwann cells (small arrows) are stained 
mainly in the perinuclear region. Additionally, a ftat 
lang cell (kmg arrow) displays also mainly perinu-
clear staining. In bolb cases nuclei are sparcd. (b, 
phase contrast) Whole antiserum diluted 1:500 was 
usod. Bar, so pm. 
trophic acti.vity for ciliary neurons which cannot be blocked 
by the CNTF-neutralizing antiserum. The molecule respon-
sible fur this effect is unknown so far. NGF and BDNF which 
are synthesized by Schwann cells are not active on ciliary 
neurons. 
The release of CNTP-like activity by cultured Schwann 
cells has not been discussed in a recent study (1), wherein 
a polyclonal antiserum against mouse NGF was shown to 
substantially reduce survival activity of Schwann cell-oon-
ditioned media measured on dissociated chick EtO DRG 
neurons. This reduction was interpreted as a cross-reactivity 
ofthe antiserum with BDNF-1ike molecules. Spinal ganglion 
neurons of this age are, however, responsive to CNTF (5) 
and the presence of CNTF-like activity in supernatants of 
Schwann cells cultured under different oonditions has been 
demonstrated (45, 63, and the present study). Thus it is not 
clear whether particu1ar culture conditions can account for 
the lack of CNTF-like activity in this study or whether the 
NGF-antiserum used may have effects in addition to the ones 
discussed by the authors. The chick nodose ganglion assay 
used in the present study for the detection ofBDNF is highly 
sensitive to CNTF. Application of recombinant CNTF sup-
pons the survival of at least 40% ofthe plated neurons (52). 
Trealment ofScbwann cell conditioned media with neutro1iz-
ing anti-CNTF antibodies agmn demonstrated the effect of 
CNTF-like molecules in tbis assay. Fot these reasons, we 
decided to routinely include anti-CNTF antibodies in 011 no-
dose bioassays at a concentration high enough to reliably 
block 1 ng/ml of recombinant rat CNTE The data obtained 
in the nodose bioassay are consistent with tbe assumption 
mal Schwann ceUs secrete nearly satutating amounts of 
BDNF-like activity. Recently, the effects of Schwann cell 
conditioned media on the survival of EIO DRG neurons and 
on neurite outgrowth from retinal explants has been de-
scribed which are in agreement with the present results (1). 
Others have also described neurotrophic activities of 
Schwann ceU-conditioned media which could not be neutra!-
ized by NGF antisera. However, again the assay systems used 
did not exclude interference by CNTF (3. 45, 49, 63, 70). 
Localization 01 BDNF-like Jmmunoreactivity in 
Cultured Schwann Cells 
Inununostaining was used to provide further evidence for the 
presence ofBDNF in Schwann cells. The homogenous stain-
ing of Schwann cells in pure or mixed cu1tures suggests that 
at least in culture all Schwann cells contribute to BDNF 
production. There seems to be a second cell type present at 
low abundance which is capable of synthesizing or intemal-
izing BDNF-immunoreactive material . Sciatic fibroblasts, 
however, do not shOW" delectable immunostaining. This find-
ing is in agreement with tbe amounts of BDNF mRNA found 
in cultured sciatic fibroblasts which are so low tbat they can 
easily be explained by the presence of contaminating 
Schwann cells. This is in contrast to Northem blotting 
results oblained by otbers in cultures of ral dermal fibm-
blasts (1). These discrepancies might be due eitber to 
ditferentio1 expression of BDNF in various fibroblast sub~ 
populations or 10 contaminating cel! types. 
lt is inleresting to note that we detected an exc1usively r::y-
toplasmic inununoreactivity in Schwann cells. This is in 
contrast 10 the observations made on BDNF-syntbesizing 
neurons in the CNS (67). Although the significance and 
structural basis of a polentio1 nuclear localization of BDNF 
are nOl known, this finding demonstrates that nuclear loco1~ 
ization is not an inevitable consequence ofBDNF synthesis. 
We conc1ude mat there is good evidence that Schwann 
cells in culture and in lesioned peripheral nerves produce 
and secrete two different s1tUcturally related neurotrophins, 
NGF and BDNF. Production of neurotrophins might be 
beneficio1 Cor regenerating neurons. Altbough both neurotro-
phins act on spinal ganglion neurons their synthesis is 
ditferentially regulated in the nerve sheath, suggesting tbat 
the requirements ror neurotrophins change with ongoing 
regeneration. It has been suggested that reexpression of the 
low affinity NGF receptor (pl5) on Schwann ceIJs in de~ 
gene rating axons plays a role in the accumulation and pre-
sentation ofNGF 10 regenerating axons (58). However, both 
NGF and BDNF bind to p75 (SO). Considering the much 
slower dissociation from p75 of BDNF as compared to NGF 
(50) , and the high concentrations of BDNF produced after 
nerve lesion, it is more like1y that BDNF rather than NGF 
is being presented 10 regrowiog axons. 
Our results may partially explain the beneficial effects of 
peripheral nerve or Schwann cell grafts in CNS Jesions. Such 
grans allow partial regeneration and survivaI of retinaI gan-
glion cells after optic nerve transsection (39, 64), regrowth 
of cholinergic tibers after fimbria-fornix lesions 09, 32, 66) 
and seem 10 support mesencephalic grafts (12, 17,62). This 
interprelation is in agreement witb in vitro studies showing 
!hat BDNF supports embryonie (31) and adult retinal gan-
glion cells (59), embl)Unic cholinergic (2), and dopaminer~ 
gic neurons (30). Hence the success of these grafts might be 
explained by the combination of a permissive substrate (SI) 
with an appropriate neurolrOphic factor(s). 
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